These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8586026)

  • 21. Effects of betahistine and of its metabolites on vestibular sensory organs.
    Botta L; Mira E; Valli S; Zucca G; Benvenuti C; Fossati A; Soto E; Guth P; Valli P
    Acta Otorhinolaryngol Ital; 2001 Jun; 21(3 Suppl 66):24-30. PubMed ID: 11677836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives on the pharmacotherapy of vertigo.
    Zee DS
    Arch Otolaryngol; 1985 Sep; 111(9):609-12. PubMed ID: 3875336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histaminergic System and Vestibular Function in Normal and Pathological Conditions.
    Tighilet B; Trico J; Marouane E; Zwergal A; Chabbert C
    Curr Neuropharmacol; 2024; 22(11):1826-1845. PubMed ID: 38504566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vestibular suppressant drugs.
    Rubin W
    Arch Otolaryngol; 1973 Feb; 97(2):135-8. PubMed ID: 4405571
    [No Abstract]   [Full Text] [Related]  

  • 25. Vertigo Perception and Quality of Life in Patients after Surgical Treatment of Vestibular Schwannoma with Pretreatment Prehabituation by Chemical Vestibular Ablation.
    Čada Z; Balatková Z; Chovanec M; Čakrt O; Hrubá S; Jeřábek J; Zvěřina E; Profant O; Fík Z; Komarc M; Betka J; Kluh J; Černý R
    Biomed Res Int; 2016; 2016():6767216. PubMed ID: 28053986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental vestibular pharmacology: a minireview with special reference to neuroactive substances and antivertigo drugs.
    Matsuoka I; Ito J; Takahashi H; Sasa M; Takaori S
    Acta Otolaryngol Suppl; 1984; 419():62-70. PubMed ID: 6399658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study.
    Parfenov VA; Golyk VA; Matsnev EI; Morozova SV; Melnikov OA; Antonenko LM; Sigaleva EE; Situkho MI; Asaulenko OI; Popovych VI; Zamergrad MV
    PLoS One; 2017; 12(3):e0174114. PubMed ID: 28358888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vestibular vertigo].
    Henn V
    Schweiz Rundsch Med Prax; 1984 Mar; 73(10):315-8. PubMed ID: 6608776
    [No Abstract]   [Full Text] [Related]  

  • 29. [Side effects of drugs on the equilibrium].
    Scherer H
    Laryngol Rhinol Otol (Stuttg); 1986 Sep; 65(9):467-9. PubMed ID: 3491268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of vertigo.
    Neuhauser HK
    Curr Opin Neurol; 2007 Feb; 20(1):40-6. PubMed ID: 17215687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vestibular effects of lidocaine intratympanic injection in rats.
    Lee HH; Kim MJ; Jo YK; Kim JY; Han GC
    Hum Exp Toxicol; 2014 Nov; 33(11):1121-33. PubMed ID: 24505049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The origins of vestibular science.
    Wiest G
    Ann N Y Acad Sci; 2015 Apr; 1343():1-9. PubMed ID: 25766734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Optico-vestibular motion disease, altitude vertigo and clinical forms of vertigo].
    Brandt T
    Fortschr Med; 1976 Jul; 94(20-21):1177-82. PubMed ID: 8363
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-induced true vertigo and balance disorders.
    Prescrire Int; 2015 Jan; 24(156):18. PubMed ID: 25729826
    [No Abstract]   [Full Text] [Related]  

  • 35. Vestibular suppressants after canalith repositioning in benign paroxysmal positional vertigo.
    Kim MB; Lee HS; Ban JH
    Laryngoscope; 2014 Oct; 124(10):2400-3. PubMed ID: 24782447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into vestibular neuropharmacology: from bench to bedside.
    Chabbert C
    J Vestib Res; 2013; 23(3):107-11. PubMed ID: 24177343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New prospects in the treatment of vertigo].
    Sauvage JP; Bessède JP; Orsel S; Morin R
    Rev Prat; 1989 Feb; 39(4):279-83. PubMed ID: 2704944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical vestibular indicator and its use in the diagnosis of vertigo].
    Miszke A; Rapacz K
    Otolaryngol Pol; 1991; 45(1):67-9. PubMed ID: 2052371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-entry blockers in the treatment of vestibular disorders.
    Pfaltz CR; Aoyagi M
    Acta Otolaryngol Suppl; 1988; 460():135-42. PubMed ID: 3074613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vertigo drug therapy--merely drug vertigo? Vertigo from the pharmacologic viewpoint].
    Fleck C
    Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):501-7. PubMed ID: 10996941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.